We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$316M
AUM Growth
-$29.1M
Cap. Flow
-$30M
Cap. Flow %
-9.48%
Top 10 Hldgs %
19.77%
Holding
567
New
205
Increased
77
Reduced
78
Closed
207

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$8.43M
2
FDX icon
FedEx
FDX
+$7.9M
3
IBM icon
IBM
IBM
+$6.03M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$5.99M
5
T icon
AT&T
T
+$5.41M

Sector Composition

Rank Sector Weight
1 Technology 28.27%
2 Consumer Discretionary 18.11%
3 Communication Services 14.57%
4 Industrials 11.75%
5 Healthcare 6.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
101
McKesson
MCK
$100B
$927K 0.29%
3,731
-869
-19% -$191K
FIVE icon
102
Five Below
FIVE
$11.4B
$924K 0.29%
4,465
-700
-14% -$138K
OMC icon
103
Omnicom Group
OMC
$23.5B
$916K 0.29%
+12,500
New +$889K
LI icon
104
Li Auto
LI
$13.1B
$915K 0.29%
28,500
-4,900
-15% -$151K
GEN icon
105
Gen Digital
GEN
$16B
$912K 0.29%
35,100
+23,200
+195% +$587K
P
106
Everpure Inc
P
$24B
$906K 0.29%
27,842
+19,236
+224% +$558K
ISRG icon
107
Intuitive Surgical
ISRG
$128B
$898K 0.28%
+2,500
New +$860K
AU icon
108
AngloGold Ashanti
AU
$40.4B
$895K 0.28%
42,636
+28,136
+194% +$548K
SNOW icon
109
Snowflake
SNOW
$93.5B
$890K 0.28%
+2,626
New +$915K
BX icon
110
Blackstone
BX
$105B
$880K 0.28%
6,800
-14,600
-68% -$1.95M
AXON
111
Axon Enterprise
AXON
$42B
$866K 0.27%
+5,518
New +$926K
WBA
112
DELISTED
Walgreens Boots Alliance
WBA
$863K 0.27%
16,543
+2,983
+22% +$144K
APD icon
113
Air Products & Chemicals
APD
$65.2B
$860K 0.27%
+2,826
New +$830K
SONO icon
114
Sonos
SONO
$1.85B
$858K 0.27%
28,797
-8,403
-23% -$267K
HOG icon
115
Harley-Davidson
HOG
$2.63B
$851K 0.27%
+22,566
New +$842K
MCO icon
116
Moody's
MCO
$84.1B
$848K 0.27%
+2,172
New +$838K
RHI icon
117
Robert Half
RHI
$3.98B
$831K 0.26%
7,456
+700
+10% +$77.9K
AZN icon
118
AstraZeneca
AZN
$266B
$821K 0.26%
7,050
-7,700
-52% -$906K
ELAN icon
119
Elanco Animal Health
ELAN
$12.6B
$820K 0.26%
28,900
+3,778
+15% +$118K
TLRY icon
120
Tilray
TLRY
$490M
$811K 0.26%
+11,540
New +$1.16M
JNPR
121
DELISTED
Juniper Networks
JNPR
$807K 0.26%
22,600
+13,500
+148% +$422K
KSS icon
122
Kohl's
KSS
$2.05B
$807K 0.26%
+16,348
New +$835K
OKTA icon
123
Okta
OKTA
$24.1B
$807K 0.26%
+3,600
New +$858K
PARA
124
DELISTED
Paramount Global Class B
PARA
$799K 0.25%
26,461
-15,439
-37% -$532K
UAA icon
125
Under Armour
UAA
$3.02B
$790K 0.25%
37,300
+13,500
+57% +$306K

Similar funds

Bayesian Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Bayesian Capital Management held 567 positions worth $316M, down 8.4% from $345M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Bayesian Capital Management withdrew a net $30M in Q4 2021, closing 207 positions and reducing 78 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Bayesian Capital Management opened a new position in Oracle worth $7.83M.

  • Bayesian Capital Management's largest Q4 2021 buy was Oracle: 89,800 shares worth $7.83M.
  • Bayesian Capital Management added most to FedEx in Q4 2021, an estimated $7.9M increase.
  • Bayesian Capital Management's biggest Q4 2021 reduction was Micron Technology, cutting an estimated $9.92M.
  • Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2021, selling an estimated $17.5M.
  • Bayesian Capital Management's ten largest holdings make up 20% of its $316M portfolio in Q4 2021.
  • Bayesian Capital Management opened 205 new positions and closed 207 in Q4 2021.
  • Bayesian Capital Management's portfolio value fell 8.4% quarter-over-quarter to $316M.

Based on Bayesian Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.